Equity
€341,877 ▲ 126%
Equity rose in 2025 from €150,967 to €341,877.
OPHES
Overview
Lifetime
2 annual accounts with figures on one time axispeak €250,522 (2025)
€250,522▲ 30.5%
peak €190,909 (2025)
€190,909▲ 29.0%
peak €341,877 (2025)
€341,877▲ 126%
€100,188▲ 124%
Board1 name since 2023
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €192,036 to €250,522Result from €147,967 to €190,909Equity from €150,967 to €341,877Debts from €44,816 to €100,188Cash from €138,641 to €373,307
Key points
from the 2025 annual accountsTurnover
≈ €380,000 estimated
The micro format states no turnover.
Position in the sector
€190,909
Higher net result than 87% of companies in human health. Sector median €59,542 · 21,298 companies.
2025 accounts filed 31 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as OPHES has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for OPHES. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0803014696
Incorporation
Founding capital of €3,000, 100 shares · Founder: (comparant) · Appointment: (director) · published on 23-06-2023 · Gazette deed
First establishment
Avenue de l'Observatoire 217, Liège
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| OPHES Liège | €442,065 | €250,522 | 77.3% | - |
| Docteur Félicie LORTHIOIR Liège | €462,869 | €285,010 | 30.0% | - |
| HEMERAD Liège | €488,041 | €233,237 | 84.4% | - |
| Docteur Léva J.M. Liège | €392,336 | €245,036 | 94.0% | - |
| Docteur Aurélien CAGNINA Esneux | €405,293 | €259,569 | 5.2% | - |
| Docteur BOCA Tarquin Liège | €453,757 | €284,505 | 84.0% | - |
| MKB Anesthésie Sprimont | €454,534 | €287,455 | 91.8% | - |
These companies have the same main activity as OPHES: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €392,000 and €488,000, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 21-06-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.350.445.4044000 Liège, since 21-06-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 31-12-2025
Annual accounts 2025
- €250,522▲ 30.5%
- €190,909▲ 29.0%
- €341,877▲ 126%
- €442,065▲ 126%
- Filing
- Filed on 31-08-2026
Insights on OPHES
OPHES has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €341,877 and a net result of €190,909.
Its solvency ranks better than 66% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 31-08-2026, 31 days late€250,522
▲ 30.5%
€250,522
▲ 30.5%
€190,909
▲ 29.0%
€341,877
▲ 126%
77.3%
▲ 0.2 percentage points
4.41
▲ 0.04
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €380,000. Estimated: probably between €340,000 and €520,000.
Balance sheet
balance sheet total €442,065 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
77.3%
Higher than 66% of 21,311 companies in 2025.
4.41
Higher than 65% of 20,862 companies in 2025.
43.2%
Higher than 78% of 21,162 companies in 2025.
OPHES
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: top quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
442,065 | 195,783 | |
29/58 |
442,065 | 195,783 | |
40/41 |
1,674 | - | |
40 |
1,378 | - | |
41 |
296 | - | |
54/58 |
373,307 | 138,641 | |
490/1 |
67,084 | 57,142 | |
| Balance sheet: equity and liabilities | |||
10/49 |
442,065 | 195,783 | |
10/15 |
341,877 | 150,967 | |
10/11 |
3,000 | 3,000 | |
13 |
338,000 | - | |
133 |
338,000 | - | |
14 |
877 | 147,967 | |
17/49 |
100,188 | 44,816 | |
42/48 |
100,188 | 44,816 | |
45 |
100,188 | 43,516 | |
450/3 |
100,188 | 40,766 | |
454/9 |
- | 2,750 | |
47/48 |
- | 1,300 | |
| Income statement | |||
9900 |
250,522 | 192,036 | |
9901 |
250,522 | 192,036 | |
65/66B |
190 | 153 | |
65 |
190 | 153 | |
9903 |
250,332 | 191,883 | |
67/77 |
59,423 | 43,916 | |
9904 |
190,909 | 147,967 | |
9905 |
190,909 | 147,967 | |
| Appropriation of the result | |||
9906 |
338,877 | 147,967 | |
14P |
147,967 | - | |
691/2 |
338,000 | - | |
6921 |
338,000 | - | |
| Document | |||
The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 31-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank2025 annual accounts filed 31 days after the deadline. Filed on 31 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00485067.
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 234,666 | - | ||
| 341,877 | 150,967 | ||
| 77.3% | 77.1% | ||
| 4.41 | 4.37 | ||
| 0.29 | 0.30 | ||
| 55.8% | 98.0% | ||
| 43.2% | 75.6% |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on OPHES
The operating result for 2025 is 30% higher than in 2024.
Debt's share of the balance-sheet total falls from 22.9% to 22.7%. Equity and debt are higher.
Board & ownership
Board
1 director, since incorporationMandates through the years
1 name, the dashed line is todayDirector
Board
Mandates as a list
-
- Director, appointed by deed of 23-06-2023, still in office
Control
Founder
This company
OPHES
Equity €341,877
Profit €190,909 in 2025
Capital
- Contribution
- €3,000
- Shares
- 100
- Contribution per share
- €30
- Equity per share
- €3,419 in 2025
- Source
- deed of 23-06-2023
Articles of association
deed of 23-06-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of May at 17:00
Shareholders
At incorporation
deed of 23-06-2023 ↗
- 100 shares (100%) · €3,000 in cash
Network & group
No group
OPHES has no parent and no holdings in its annual accounts. is the only director.
At the same address
Avenue de l'Observatoire 217, 4000 Liège · 5 other companies| JAP CONSULTING SERVICES
registered office since 12-01-2017 · founded in 2016 |
turnover €27,088 (2025) 0668.510.043 |
| STALE6
registered office since 02-04-2024 · founded in 2024 |
total assets €110,304 (2025) 1007.896.514 |
| INAMIQ
establishment since 01-07-2025 · founded in 2025 |
total assets €46,335 (2025) 1024.740.167 |
| Tasquin, Guillaume (sole trader)
establishment since 04-08-2025 |
founded in 2025 1026.212.785 |
| Fauconnier, Micheline (sole trader)
establishment since 03-06-1992 |
founded in 1992 0748.225.336 |
Connections & network
1 connected companyThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
via · Director · deed of 20-11-2025
Founded in 1993 · total assets €325,845 (2025)
Timeline
Timeline
6 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 31 days late
2025
Equity above €200,000 equity €341,877 ▲126% With a profit in every financial year since 2024, equity grows to €341,877.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0803014696
Annual accounts 2024 filed PDFmicro format · 16 days before the deadline
2023
IncorporationFounding capital of €3,000, 100 shares · Founder: (comparant) · Appointment: (director) · published on 23-06-20234 points ▸
- Founder, (comparant)
- Founding capital, €3,000, 100 shares
- 100 shares
- Director appointment,
- The deed holds 2 more points.
First establishment Avenue de l'Observatoire 217, Liège
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 0803.014.696
- VAT number
- BE 0803.014.696
- Peppol ID
- 0208:0803014696
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 21-06-2023
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of May at 17:00deed of 23-06-2023 (in French)
- Peppol
- Reachable since 31-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- OPHES in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 23-06-2023 (in French)
Activities
NACEBEL 202586220
Specialist medical practice main activity
Codes under NACEBEL 2008
86220
Human health activities main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “La société a pour objet l'exercice de la médecine ainsi que l’exercice de toutes les activités jugées compatibles par l’Ordre des Médecins…”deed of 23-06-2023 (in French)
9 activities
- La société a pour objet l'exercice de la médecine ainsi que l’exercice de toutes les activités jugées compatibles par l’Ordre des Médecins.
- La médecine est exercée au nom et pour le compte de la société par les personnes physiques ayant le titre de docteur en médecine.
- Les honoraires sont perçus par et pour la société.
- La société exercera son activité professionnelle conformément au cadre légal,règlementaire et déontologique qui lui est applicable.
- L'objet ne pourra être poursuivi que dans le respect des prescriptions d'ordre déontologiques notamment celles relatives au libre choix du médecin par le patient,à l'indépendance diagnostique et thérapeutique du médecin,au respect du secret médical,à la dignité et à l'indépendance professionnelle du praticien.
- La société s'interdit toute exploitation commerciale de la médecine,toute forme de collusion directe ou indirecte,de dichotomie ou de surconsommation.
- La société a également pour objet à titre accessoire et suivant des modalités arrêtées par les actionnaires en ce qui concerne les investissements,la gestion et la valorisation d’un patrimoine immobilier,notamment par l’achat,de la pleine propriété ou de droits réels,la vente,la location,la mise en location,la construction,le tout au sens le plus large,pour autant que n’en soit altéré ni son caractère civil ni sa vocation exclusivement médicale.
- Elle pourra notamment acquérir un terrain,construire un immeuble,acquérir la pleine propriété ou des droits réels dans un immeuble,louer ou sous louer tout immeuble dans le but d’y exercer ses activités médicales,d’y établir son siège ou d’y loger ses dirigeants et les membres de leur famille,à titre de résidence principale ou secondaire,à titre gratuit ou rémunéré.
- Dans le cadre de cet objet,la société peut accomplir tout investissement,toute opération civile,mobilière ou immobilière et les gérer pour son compte propre.
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Avenue de l'Observatoire 217 registered office 4000 Liège | 21-06-2023 | 2.350.445.404 |
Buildings and parcels at the address
- Ground area
- 1.6 ha
- Buildings
- 496 m²
- Volume, LiDAR
- 12,592 m³
- Tallest building
- 28.6 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 62814C0356/00D000 | 1.6 ha | 1 · 496 m² | 28.6 m · 9 |